In the sci-fi film "A.I. Artificial Intelligence," a couple adopts a robot boy named David. This little robot, possessing self-awareness and emotions, yearns to become part of the human world and embarks on a fantastical journey in search of maternal love...
While current technology hasn't yet reached the advanced level depicted in the film, the humanoid robot sector is in a phase of rapid growth. A number of well-known tech companies have emerged in China, including Unitree Robotics, Zhiyuan Robotics, and UBTECH ROBOTICS.
As the "first humanoid robot stock" on the Hong Kong market, UBTECH ROBOTICS announced at the end of June the launch of three full-size, ultra-bionic humanoid robot products. This new narrative in the consumer-grade bionics segment has stirred market enthusiasm and quickly sparked widespread discussion.
Simultaneously, the company announced that pre-orders for its U1 model had exceeded 13,000 units across all channels. This rapid uptake of 13,000 pre-orders quickly ignited external imagination about the company's potential "second growth curve" in the consumer market.
Stimulated by the bionic robot news, the company's stock price in the capital markets experienced a rollercoaster ride from a "peak" to "cooling off." Behind this volatile price action lies market debate over UBTECH ROBOTICS's bionic robots, with focus on issues including safety and ethics, product battery life, and the sustainability of market demand.
Looking beyond the surface, however, the core issue—whether technical or ethical—is that UBTECH ROBOTICS seems intent on pursuing everything in the field of embodied intelligence. From industrial applications to home care, and now to emotional companionship bionics, all areas have become key business focuses for the company, raising questions about whether it can successfully navigate them all.
For UBTECH ROBOTICS, this situation brings both profitability pressure and competitive pressure.
Ultra-Bionic Humanoid Robot Products: Initial Hype Followed by Cooling
The company's product portfolio has further expanded. Beyond its industrial humanoid robots, commercial humanoid robots, wheeled humanoid robots, and panda robots, the firm recently added ultra-bionic humanoid robots to its lineup.
On June 30, 2026, at its Global Launch Event in Shenzhen, UBTECH ROBOTICS unveiled its full-size ultra-bionic humanoid robot series, the U-World U1. This series includes three models: the U1 Lite (upper body version), the U1 Ultra (high-dynamics full-body version), and the U1 Pro (high-spec full-body version), with prices ranging from 119,800 yuan to 990,000 yuan.
According to the company's website, the full-size ultra-bionic humanoid U1 series features ultra-bionic soft skin, art-grade 1:1 human modeling with clearly visible pores, blood vessels, and fingerprints. The application scenarios are divided into consumer applications (daily companionship, emotional support, lifestyle aesthetics, and social assistance) and commercial service applications (greeting and reception, housekeeping services, elderly companionship, etc.).
Reports indicate that pre-orders for the UBTECH ROBOTICS U1 series ultra-bionic humanoid robots have surpassed 13,000 units.
Spurred by this news, the company's stock price surged as much as 18% on June 30, closing up 7.48%. Subsequently, however, its share price volatility intensified. It plunged 9.92% on July 2, then soared 17.60% on July 3, followed by six consecutive days of decline from July 6 to 13, resulting in a cumulative drop of 23.92%.
Why such significant divergence in the secondary market reaction, moving from initial hype to cooling?
External scrutiny primarily focuses on three major issues. The first is safety and ethical concerns. The company positions its bionic robots for emotional companionship, not as boyfriends, girlfriends, or partners. However, some voices express concern that bionic robots could potentially collect personal private information, and data breaches could have unthinkable consequences.
The second is product performance. Although the bionic robots are manufactured to be highly realistic, their battery life reportedly does not exceed four hours, limiting product practicality. The industry consensus is that battery life meeting daily life scenarios should be at least 8 to 10 hours.
The third is the sustainability of market demand. For ordinary consumers, purchasing a robot costing over one hundred thousand or even several hundred thousand yuan requires substantial financial strength. While emotional companionship presents a "novel" business opportunity for single individuals, it remains uncertain whether this demand will persist if market enthusiasm wanes.
UBTECH ROBOTICS has responded, stating that short battery life for full-size humanoid robots is currently a common industry-wide phenomenon. It also reiterated that the positioning of bionic robots for emotional companionship is a direction encouraged and recognized by national policies. Some analysts believe that for humanoid robots to fully enter mainstream households in the future, several hurdles must be crossed: aligning technology with actual home needs, reducing costs, maturing the industrial support ecosystem, and perfecting consumer service systems and commercial operation models. UBTECH ROBOTICS's ultra-bionic humanoid robots are currently seen as having "just taken the first step." The company's products, with 13,000 units on order, are scheduled to begin batch deliveries in September, when the U1 bionic robot series will undergo large-scale real-world scenario testing.
If the actual user experience falls short of promotional expectations, it could not only risk customer order cancellations and further declines in order conversion rates but also potentially impact the company's operational development.
Intensifying Competition and Six Consecutive Years of Losses: Can a New Direction Solve the "Anxiety"?
UBTECH ROBOTICS was founded in 2012. It initially entered the market with consumer-grade robots, later expanding into the B2B market, including automotive companies, by launching industrial humanoid robots. Currently, the company primarily focuses on three scenarios: industrial manufacturing, commercial services, and family companionship.
At present, the company is implementing a three-pronged parallel development strategy: forming deep strategic partnerships with some European, American, and Japanese companies in the industrial humanoid robot field; continuously expanding diverse commercial application scenarios like retail stores and cultural tourism in the commercial service robot sector; and in the home market, its ultra-bionic companion humanoid robots are in the initial stages of emotional companionship.
The company's founder, Zhou Jian, has stated that UBTECH ROBOTICS is "walking on three legs." In terms of resource allocation, the company plans to devote 50% of its efforts to commercial and industrial applications and 50% to the home market.
It's not difficult to see that the company's operational focus has shifted. Behind this directional choice lies the "anxiety" of this leading player.
On one hand, UBTECH ROBOTICS faces increasing competitive pressure, and its investment "uniqueness" has diminished.
Data from the well-known research firm Omdia shows that in 2025, the top three global humanoid robot shipments were Zhiyuan Robotics (5,168 units), Unitree Robotics (4,200 units), and UBTECH ROBOTICS (1,000 units). Their respective market shares were approximately 38.8%, 31.54%, and 7.5%. By comparison, UBTECH ROBOTICS's market share lags behind Zhiyuan Robotics and Unitree Robotics by over 24 percentage points.
Furthermore, according to predictions from TrendForce, China's humanoid robot market output is expected to grow 94% year-on-year in 2026, with Unitree Robotics and Zhiyuan Robotics projected to account for nearly 80% of shipment share combined.
As the industry gradually forms a duopoly competitive landscape, another wave of cross-sector players is entering the fray. According to incomplete statistics, companies including Xiaomi, GAC Group, XPeng, and Chery Automobile have successively entered the humanoid robot field.
Although the humanoid robot industry has yet to declare a definitive winner, the trend points toward intensifying competition.
It is worth noting that on July 2 of this year, Unitree Robotics received approval for its IPO registration, bringing it a step closer to listing. In the past, genuine humanoid robot concept stocks in the secondary market were few. Once Unitree Robotics and other robot companies achieve listing, the number of investment options available to investors will increase.
On the other hand, UBTECH ROBOTICS has yet to turn a profit, with profitability pressure looming overhead.
Financial reports show that from 2020 to 2025, the company's net profit attributable to shareholders recorded losses of 707 million yuan, 920.2 million yuan, 974.8 million yuan, 1.234 billion yuan, 1.124 billion yuan, and 703.2 million yuan, respectively. The total loss over six years exceeds 5.6 billion yuan. Looking at peers, Unitree Robotics had already achieved profitability by 2024. In terms of the timeline to profitability, UBTECH ROBOTICS lags behind Unitree Robotics.
Previously, the company focused on the industrial humanoid robot track. However, this field may face homogenized hardware competition in the future, with value boundaries largely confined to integrated equipment solution packages and limited potential for derivative value-added services. Now, with Unitree Robotics and Zhiyuan Robotics gaining strong momentum, time is running out for UBTECH ROBOTICS. It needs to find a new growth curve to escape its loss-making situation.
UBTECH ROBOTICS recognizes that humanoid robots for home scenarios, represented by ultra-bionic humanoid robots, offer greater imaginative potential. Industrial humanoid robots generate hardware revenue, while ultra-bionic humanoid robots can generate ongoing ecosystem service revenue, with the latter holding higher profit potential than the former.
Before 2025, the central topic in the robot sector was "working in factories." After 2025, external attention shifted more toward the application potential in the consumer market. Ultra-bionic humanoid robots belong to one category within the "emotional value" business.
Of course, no matter how promising the commercial prospects of ultra-bionic humanoid robots may seem, they require a viable business model and successful commercial implementation. Whether UBTECH ROBOTICS can capture a share of the home companionship market "pie" will ultimately require validation through its financial reports.
Comments